Cargando…

What Have We Learned (or Expect to) From Analysis of Murine Genetic Models Related to Substance Use Disorders?

The tremendous public health problem created by substance use disorders (SUDs) presents a major opportunity for mouse genetics. Inbred mouse strains exhibit substantial and heritable differences in their responses to drugs of abuse (DOA) and in many of the behaviors associated with susceptibility to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peltz, Gary, Tan, Yalun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790171/ https://www.ncbi.nlm.nih.gov/pubmed/35095607 http://dx.doi.org/10.3389/fpsyt.2021.793961

Ejemplares similares

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models
por: Samsom, James N., et al.
Publicado: (2015)

Coronavirus Disease 2019 Outbreak in a Psychiatric Closed Ward: What We Have to Learn
por: Chun, June Young, et al.
Publicado: (2021)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?
por: Freudenberg, Lutz S., et al.
Publicado: (2022)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions
por: Grubb, Caitlyn J., et al.
Publicado: (2021)

Genetics of Obesity: What have we Learned?
por: Choquet, Hélène, et al.
Publicado: (2011)

Bibliometric Insights in Genetic Factors of Substance-Related Disorders: Intellectual Developments, Turning Points, and Emerging Trends
por: Wang, Kang, et al.
Publicado: (2021)

A Meta-Analysis of Transcranial Direct Current Stimulation on Substance and Food Craving: What Effect Do Modulators Have?
por: Chen, Jiasi, et al.
Publicado: (2020)

Genetic Differences in Dorsal Hippocampus Acetylcholinesterase Activity Predict Contextual Fear Learning Across Inbred Mouse Strains
por: Mooney-Leber, Sean M., et al.
Publicado: (2021)

Editorial: The inflammation markers in schizophrenia and bipolar disorder: Do we have promising results?
por: Arslan, Ayla, et al.
Publicado: (2023)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Complicated Grief: What to Expect After the Coronavirus Pandemic
por: Gesi, Camilla, et al.
Publicado: (2020)

Editorial: “We Know What We Are, but Know Not What We May Be”: Metacognition and Self-Awareness in the Aging Brain
por: Orfei, Maria Donata, et al.
Publicado: (2021)

What can We Learn from the Pervasive Linkage of Impulsivity and Addictive Behavior?
por: Zack, Martin
Publicado: (2010)

Exercise and Mental Health: What did We Learn in the Last 20 Years?
por: Deslandes, Andrea Camaz
Publicado: (2014)

Animal models of compulsion alcohol drinking: Why we love quinine-resistant intake and what we learned from it
por: De Oliveira Sergio, Thatiane, et al.
Publicado: (2023)

Exercise and Alcohol Consumption: What We Know, What We Need to Know, and Why it is Important
por: Leasure, J. Leigh, et al.
Publicado: (2015)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Relationships between Behavioural Addictions and Psychiatric Disorders: What Is Known and What Is Yet to Be Learned?
por: Starcevic, Vladan, et al.
Publicado: (2017)

Cortico-Cerebellar Connectivity in Autism Spectrum Disorder: What Do We Know So Far?
por: Crippa, Alessandro, et al.
Publicado: (2016)

Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain
por: Wu, Manhong, et al.
Publicado: (2022)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

Effects of 8 months of high-intensity interval training on physical fitness and health-related quality of life in substance use disorder
por: Tan, Jun, et al.
Publicado: (2023)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

The Complex Molecular Picture of Gut and Oral Microbiota–Brain-Depression System: What We Know and What We Need to Know
por: Scassellati, Catia, et al.
Publicado: (2021)

Treatment-resistant schizophrenia: How far have we traveled?
por: Pandey, Ambu, et al.
Publicado: (2022)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

SARS: What have we learned?
Publicado: (2003)

Traumatic Events and Substance Use Disorders in Adolescents
por: Basedow, Lukas A., et al.
Publicado: (2020)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study
por: Piñón-Blanco, Adolfo, et al.
Publicado: (2022)

Living with genetic risk of breast cancer: what have we learned?
por: Foster, C
Publicado: (2008)

Narcolepsy type 1: what have we learned from genetics?
por: Ollila, Hanna M
Publicado: (2020)

The COVID-19 surge in Indonesia: what we learned and what to expect
por: Tenda, Eric Daniel, et al.
Publicado: (2021)

ASD and ADHD Comorbidity: What Are We Talking About?
por: Hours, Camille, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jmk26b54ld4j74f5fkbpdm4vbl